Fresenius SE & Co. (OTCMKTS:FSNUY) Short Interest Update

Fresenius SE & Co. (OTCMKTS:FSNUY) saw a large increase in short interest in the month of August. As of August 14th, there was short interest totaling 1,029,832 shares, an increase of 796.7% from the July 30th total of 114,842 shares. Based on an average daily volume of 420,053 shares, the days-to-cover ratio is currently 2.5 days. Currently, 0.0% of the shares of the stock are sold short.

Wall Street Analysts Forecast Growth

Several brokerages recently weighed in on FSNUY. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating on shares of Fresenius SE & Co. in a research note on Thursday, August 6th. Morgan Stanley reissued an “overweight” rating on shares of Fresenius SE & Co. in a report on Tuesday, July 21st. Three equities research analysts have rated the stock with a Buy rating, Based on data from MarketBeat.com, the stock presently has a consensus rating of “Buy”.

Fresenius SE & Co. Price Performance

Shares of OTCMKTS FSNUY traded up $0.11 during trading on Wednesday, hitting $13.50. The company had a trading volume of 8,814 shares, compared to its average volume of 155,011. Fresenius SE & Co. has a 52 week low of $10.33 and a 52 week high of $33.93. The business’s 50-day moving average is $12.53 and its 200 day moving average is $12.70. The company has a market cap of $30.41 billion, a P/E ratio of 17.09 and a beta of 0.61. The company has a debt-to-equity ratio of 0.41, a quick ratio of 0.98 and a current ratio of 1.27.

Fresenius SE & Co. (OTCMKTS:FSNUY) last issued its earnings results on Wednesday, August 5th. The company reported $0.24 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.25 by ($0.01). Fresenius SE & Co. had a return on equity of 10.33% and a net margin of 6.67%.The company had revenue of $6.91 billion during the quarter, compared to analyst estimates of $6.65 billion. Equities research analysts predict that Fresenius SE & Co. will post 1.08 earnings per share for the current fiscal year.

Fresenius SE & Co. Company Profile

Fresenius SE & Co KGaA is a global healthcare group headquartered in Bad Homburg vor der Höhe, Germany. Founded in 1912 by Eduard Fresenius, the company has grown into one of the world’s leading providers of products and services for dialysis, hospitals and outpatient medical care. Trading on major European exchanges and available over the counter in the U.S. as FSNUY, Fresenius SE & Co brings together a portfolio of specialized healthcare businesses under one corporate umbrella.

The company operates through four main business segments.